Results of a phase I trial investigating vorinostat combined with sirolimus or everolimus for treatment of relapsed Hodgkin lymphoma. (Abstract only)
Home / Resource Library / Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma